Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India’s ATLAS expands to OTCs

This article was originally published in The Tan Sheet

Executive Summary

ATLAS Laboratories and Pharmaceuticals, an Indian manufacturer of Rx hormonal preparations and anti-hypertensive products, plans to enter the over-the-counter segment with a line of women's health products, the company announces Oct. 16. ATLAS Executive Director Ashwin Kapur says the New Delhi-based firm "will leverage our vertical presence in the ethical segment, to develop a strong network for OTC products" for women, whom he calls "the backbone of our society." Kapur adds the Indian OTC channel's average compound annual growth rate of 14 percent attracted the firm to the market. The company says it intends to add a large R&D facility and look for international partnerships to launch new molecules in the Indian market
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS102216

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel